What is Carboplatin?

Category: Prescription Drugs

false

See also: Docetaxel-carboplatin-trastuzumab-pertuzumab Docetaxel-carboplatin-trastuzumab (TCH) ICE regimen

Carboplatin is chemotherapy agent often used to treat ovarian cancer. It may also be used to treat a variety of other cancers including lung, head and neck, endometrial, esophageal, bladder, breast, cervical, central nervous system tumors, and germ cell tumors.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Ovarian cancer 18 9
Lung cancer 7 2
Endometrial cancer 4 7
Breast cancer 2 1
Esophageal cancer 1 0

Show all 9 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 5
Moderate 4
Mild 7
None 6

Commonly reported side effects and conditions associated with Carboplatin

Side effect Patients
Nausea 6
Fatigue 4
Hair loss 3
Peripheral neuropathy 2
Back pain 1
Diarrhea 1

Show all 15 reported side effects

Dosages

Based on patients currently taking Carboplatin

Dosage Patients
0.05 g every 3 weeks 1
545 mg every 3 weeks 1

Why patients stopped taking Carboplatin

Multiple reasons could be selected

Reason Patients
Course of treatment ended 15
Doctor's advice 3
Did not seem to work 2
Other 1
Side effects too severe 1
See all 20 patients who've stopped taking Carboplatin

Duration

Currently taking Carboplatin

Duration Patients
1 - 6 months 1
1 - 2 years 1
2 - 5 years 1

Stopped taking Carboplatin

Duration Patients
Less than 1 month 1
1 - 6 months 14
6 months - 1 year 4
1 - 2 years 1
Adherence
Adherence Evaluations
Always 18
Usually 3
Sometimes 0
Never taken as prescribed 1
Burden
Burden Evaluations
Very hard to take 2
Somewhat hard to take 6
A little hard to take 4
Not at all hard to take 10
Cost per month
Cost per month Evaluations
$200+ 2
$100-199 0
$50-99 0
$25-49 0
< $25 13
Not specified 7

What people switch to and from

Patients started taking Carboplatin after stopping:

Treatment Patients
Tamoxifen (Nolvadex) 1

Patients stopped taking Carboplatin and switched to:

Treatment Patients
Bevacizumab (Avastin) 1
Eribulin (Halaven) 1
Last updated:
There are no evaluations for Carboplatin.